SHL is basically trading at Pre-covid levels with a far less demanding P/E. It's never going to shoot the lights out. But it will continue to grow in time. There's been a host of companies that have been smashed post covid. This is one of them. I don't see it as problematic to have SHL as part of a diversified long term portfolio.
Pathology services are here to stay.
Here's some charts I posted on another thread. Over time, it's been bottom left/top right. Long term holders would be unphased.
Note: Past performance is no indication of future performance.
All the best.
10yr SP Chart
Dividend History Chart
SHL 10yr vs XJO vs BHP
SHL is basically trading at Pre-covid levels with a far less...
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.17 |
Change
0.040(0.15%) |
Mkt cap ! $13.05B | |||
| Open | High | Low | Value | Volume |
| $27.30 | $27.36 | $27.01 | $16.54M | 609.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 740 | $27.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.19 | 832 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| SHL (ASX) Chart |